Humana (HUM) Stock Forecast & Price Target

Compare

2,640 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Moderate Buy

8 Buy

11 Hold

1 Sell

Based on 20 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$290.87

▲(11.59% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $290.87 with a high forecast of $341.00 and a low forecast of $231.00. The average price target represents a 11.59% change from the last price of $260.67.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"228":"$228","285":"$285","342":"$342","256.5":"$256.5","313.5":"$313.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":341,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$341.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":290.87,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$290.87</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":231,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$231.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[228,256.5,285,313.5,342],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.23,249.8276923076923,257.4253846153846,265.0230769230769,272.6207692307692,280.21846153846155,287.81615384615384,295.4138461538462,303.01153846153846,310.60923076923075,318.2069230769231,325.8046153846154,333.40230769230766,{"y":341,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.23,245.97153846153844,249.71307692307693,253.45461538461538,257.19615384615383,260.9376923076923,264.67923076923074,268.4207692307692,272.1623076923077,275.90384615384613,279.6453846153846,283.3869230769231,287.1284615384615,{"y":290.87,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,242.23,241.36615384615385,240.50230769230768,239.63846153846154,238.77461538461537,237.91076923076923,237.04692307692306,236.18307692307692,235.31923076923076,234.45538461538462,233.59153846153845,232.7276923076923,231.86384615384617,{"y":231,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":289.07,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.07,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":290.18,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":262.84,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.7,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":308.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":246.77,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":278.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.23,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$341.00

Average Price Target$290.87

Lowest Price Target$231.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Erin Wright

Morgan Stanley

$277→$262

Hold

0.51%

Upside

Reiterated

12/18/25

Humana price target lowered to $262 from $277 at Morgan StanleyHumana price target lowered to $262 from $277 at Morgan Stanley

Andrew Mok CFA

Barclays

$234

Hold

-10.23%

Downside

Reiterated

12/17/25

Analysts Offer Insights on Healthcare Companies: AnaptysBio (NASDAQ: ANAB), Novan (NASDAQ: NOVN) and Humana (NYSE: HUM)

Matthew Gillmor CFA

KeyBanc

Hold

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

David Toung

Argus Research

Hold

―

Reiterated

12/08/25

Humana seeking path to higher profitability, says ArgusHumana seeking path to higher profitability, says Argus

David Windley

Jefferies

$313

Buy

20.08%

Upside

Upgraded

12/05/25

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$300→$285

Hold

9.33%

Upside

Reiterated

11/10/25

Truist Financial Sticks to Its Hold Rating for Humana (HUM)

Ann Hynes

Mizuho Securities

$345→$310

Buy

18.92%

Upside

Reiterated

11/07/25

Humana price target lowered to $310 from $345 at MizuhoHumana price target lowered to $310 from $345 at Mizuho

George Hill

Deutsche Bank

$250→$231

Hold

-11.38%

Downside

Reiterated

11/07/25

Humana price target lowered to $231 from $250 at Deutsche BankHumana price target lowered to $231 from $250 at Deutsche Bank

Stephen Baxter

Wells Fargo

$347→$290

Buy

11.25%

Upside

Reiterated

11/07/25

Humana price target lowered to $290 from $347 at Wells FargoHumana price target lowered to $290 from $347 at Wells Fargo

Elizabeth Anderson CFA

Evercore ISI

$285

Hold

9.33%

Upside

Reiterated

11/07/25

Humana (HUM) Receives a Hold from Evercore ISI

Michael Wiederhorn

Oppenheimer

$310

Buy

18.92%

Upside

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

$300

Hold

15.09%

Upside

Reiterated

11/06/25

Humana's Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges

Ryan Langston

TD Cowen

$260

Hold

-0.26%

Downside

Reiterated

11/06/25

Humana's Hold Rating: Balancing Positive Earnings with Strategic Challenges

Sarah James

Cantor Fitzgerald

$290

Hold

11.25%

Upside

Reiterated

11/05/25

Cantor Fitzgerald Keeps Their Hold Rating on Humana (HUM)

Ben Hendrix

RBC Capital

$322

Buy

23.53%

Upside

Reiterated

11/05/25

Humana (HUM) Gets a Buy from RBC Capital

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Erin Wright

Morgan Stanley

$277→$262

Hold

0.51%

Upside

Reiterated

12/18/25

Humana price target lowered to $262 from $277 at Morgan StanleyHumana price target lowered to $262 from $277 at Morgan Stanley

Andrew Mok CFA

Barclays

$234

Hold

-10.23%

Downside

Reiterated

12/17/25

Analysts Offer Insights on Healthcare Companies: AnaptysBio (NASDAQ: ANAB), Novan (NASDAQ: NOVN) and Humana (NYSE: HUM)

Matthew Gillmor CFA

KeyBanc

Hold

―

Reiterated

12/12/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Humana (NYSE: HUM)

David Toung

Argus Research

Hold

―

Reiterated

12/08/25

Humana seeking path to higher profitability, says ArgusHumana seeking path to higher profitability, says Argus

David Windley

Jefferies

$313

Buy

20.08%

Upside

Upgraded

12/05/25

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (NASDAQ: ARWR) and Humana (NYSE: HUM)

David S Macdonald

Truist Financial

$300→$285

Hold

9.33%

Upside

Reiterated

11/10/25

Truist Financial Sticks to Its Hold Rating for Humana (HUM)

Ann Hynes

Mizuho Securities

$345→$310

Buy

18.92%

Upside

Reiterated

11/07/25

Humana price target lowered to $310 from $345 at MizuhoHumana price target lowered to $310 from $345 at Mizuho

George Hill

Deutsche Bank

$250→$231

Hold

-11.38%

Downside

Reiterated

11/07/25

Humana price target lowered to $231 from $250 at Deutsche BankHumana price target lowered to $231 from $250 at Deutsche Bank

Stephen Baxter

Wells Fargo

$347→$290

Buy

11.25%

Upside

Reiterated

11/07/25

Humana price target lowered to $290 from $347 at Wells FargoHumana price target lowered to $290 from $347 at Wells Fargo

Elizabeth Anderson CFA

Evercore ISI

$285

Hold

9.33%

Upside

Reiterated

11/07/25

Humana (HUM) Receives a Hold from Evercore ISI

Michael Wiederhorn

Oppenheimer

$310

Buy

18.92%

Upside

Reiterated

11/06/25

Oppenheimer Remains a Buy on Humana (HUM)

Kevin Fischbeck

Bank of America Securities

$300

Hold

15.09%

Upside

Reiterated

11/06/25

Humana's Growth Prospects and Risks: Hold Rating Amid Unclear 2026 Projections and MLR Challenges

Ryan Langston

TD Cowen

$260

Hold

-0.26%

Downside

Reiterated

11/06/25

Humana's Hold Rating: Balancing Positive Earnings with Strategic Challenges

Sarah James

Cantor Fitzgerald

$290

Hold

11.25%

Upside

Reiterated

11/05/25

Cantor Fitzgerald Keeps Their Hold Rating on Humana (HUM)

Ben Hendrix

RBC Capital

$322

Buy

23.53%

Upside

Reiterated

11/05/25

Humana (HUM) Gets a Buy from RBC Capital

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

1 Month

xxx

Success Rate

25/40 ratings generated profit

Average Return

+1.41%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +1.41% per trade.

3 Months

xxx

Success Rate

27/40 ratings generated profit

Average Return

+2.16%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 67.50% of your transactions generating a profit, with an average return of +2.16% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

25/40 ratings generated profit

Average Return

+4.04%

reiterated a buy rating last month

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +4.04% per trade.

2 Years

xxx

Success Rate

30/40 ratings generated profit

Average Return

+10.00%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +10.00% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 16 Buy Ratings, 29 Hold Ratings, and 1 Sell Ratings. HUM average Analyst price target in the past 3 months is 290.87.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is -$4.02 with a range of -$4.38 to -$3.53. The previous quarter’s EPS was $3.24. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $32.02B with a range of $31.41B to $32.39B. The previous quarter’s sales results were $32.65B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana Inc’s 12-month average price target is 290.87.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana Inc has 11.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana Inc has a consensus rating of Moderate Buy which is based on 8 buy ratings, 11 hold ratings and 1 sell ratings.

What is Humana Inc’s price target?

The average price target for Humana Inc is 290.87. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $341.00 ,the lowest forecast is $231.00. The average price target represents 11.59% Increase from the current price of $260.67.

What do analysts say about Humana Inc?

Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Detailed List of Analyst Forecasts